Grünenthal Meds
1 follower
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. T... Read more
Org chart
Christoph Stolle
Chief Executive Officer
Christoph Stolle
Collapse
Rob May
Vp, Head Of Business Development And Partner Business
Chris Fuller
Regional Brands Director (emea)
Alan King
Chief Financial Officer
Ian Povall
Head Of Commercial Operations Uk&i
Adam Higginson
Senior Omnichannel Marketing Manager
Bhavika Patel
Senior Regulatory Affairs Associate
Similar companies
Isomorphic Labs
3 followers
QuellTX
4 followers
AstraZeneca
217 followers
Life Science People
1 follower
Formation Bio
2 followers
Hikma Pharmaceuticals
6 followers
Semble
3 followers
The Health Management Academy
2 followers
Orchard Therapeutics PLC
2 followers
Catalyst Pharmaceuticals
2 followers
Aytu BioScience
2 followers
Discover companies